Sponsor Pipeline

Therapeutic Advances in Childhood Leukemia Consortium Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
5
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1/2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07686107 Trial of Revumenib Plus FLA Chemotherapy for Children With Relapsed or Refractory… Leukemia, Myeloid, Acute Not Yet Recruiting
Phase 1/2
NCT05849662 A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed… Leukemia, Juvenile Myelomonocytic Recruiting
NCT03817320 PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute… ALL, Childhood Active, Not Recruiting
Phase 1
NCT05476770 Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing… Hematologic Malignancy Recruiting
Disease Areas
Leukemia (4) Acute Lymphoblastic Leukemia (ALL) (2) Acute Myeloid Leukemia (AML) (1) Hodgkin Lymphoma (1) Myelodysplastic Syndromes (MDS) (1)
Get alerts when Therapeutic Advances in Childhood Leukemia Consortium's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free